World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 February 2024
Main ID:  NCT04565431
Date of registration: 25/08/2020
Prospective Registration: Yes
Primary sponsor: Kessler Foundation
Public title: Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
Scientific title: Biomarker for Cognitive Fatigue Using Functional Imaging in Multiple Sclerosis
Date of first enrolment: March 19, 2021
Target sample size: 25
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/ct2/show/NCT04565431
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Nancy Moore, MA
Address: 
Telephone: 973-324-8450
Email: nbmoore@kesslerfoundation.org
Affiliation: 
Name:     Nancy Moore, M.A.
Address: 
Telephone: 19733248450
Email: nbmoore@kesslerfoundation.org
Affiliation: 
Name:     John DeLuca, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Kessler Foundation
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age between 18-64

- Diagnosed with Relapsing-Remitting Multiple Sclerosis or a healthy volunteer

- If diagnosed with MS: has been newly prescribed Tysabri, but has not yet started
taking the medication

- Can read and speak English fluently

Exclusion Criteria:

- History of head injury, stroke, seizures, or any other significant neurological event
other than MS

- Flare up of MS symptoms within the past month

- History of significant psychiatric illness (for example, bipolar disorder,
schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder

- Pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal
clips on the wall of a large artery), metallic prostheses (including metal pins and
rods, heart valves, and internal hearing aids [cochlear implants]), permanent
eyeliner, implanted delivery pumps, or shrapnel fragments

- Left-handed.

- Not able to have an MRI



Age minimum: 18 Years
Age maximum: 64 Years
Gender: All
Health Condition(s) or Problem(s) studied
Multiple Sclerosis, Relapsing-Remitting
Intervention(s)
Drug: Tysabri
Primary Outcome(s)
Brain activation (BOLD signal) [Time Frame: Measured by change between 2 time points (baseline and six months after intervention)]
Secondary Outcome(s)
Fatigue onset (SDMT) [Time Frame: Measured by change between 2 time points (baseline and six months after intervention)]
Fatigue onset [Time Frame: Measured by change between 2 time points (baseline and six months after intervention)]
Secondary ID(s)
US-TYS-11640
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
St. Barnabas Medical Center
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history